Fogorvosi szemle, 1993 (86. évfolyam, 1-11. szám)

1993-04-01 / 4. szám

id hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. Br. Med. J. 280, 1340. 1980. — 106. Somjem, D. és mts.: Bone remodeling induced by physical stress is prostagladin E2 mediated. Biochem. Biophys. Acta 627, 91. 1980. — 107. Szűcs J Uraemias csont-dystrophia. Orvosképzés 48, 422. 1973. — 108. Talmaga, R. V. és mts.: An interpretation of acute changes in plasma Ca45 following parathyroid hormone administration to thyroparathyroidectomised rats. Calcif. Tiss. Res. 22, 117. 1976. — 109. Tam, S. C. és mts.: Bone biopsy in the diagnosis of primary hyperparathyroidism. In Copp. DH, Talmage, RV (eds) Endocrinology and Calcium Metabolism. Excerpta Medica Amsterdam p. 427 (abstrct) 1978. — 110. Tam, S. C. és mts.: Effect of parathyroid exctract on bone apposition and the interaction between parathyroid hormone and vitamin D. Min. Electrolyte Metab. 3, 74. 1980. — 111. Tam, S. C. és mts.: Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110, 506. 1982. 112. Tanaka, Y. & DeLuca, H. F.: The

control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch. Biochem. Biophys. 154, 566. 1973. — 113. Templeteon, A. W. és mts.: Localised osteosclerosis in hyperparathyroidism. Radiology 78, 955. 1962. — 114. Trang, L. E.: Prostaglandins and inflammation. Sem. Arth. Rheum. 9, 153. 1980. — 115. Trummei, C. L. és mts.: 25-hydroxycholecalciferol stimulation of bone resorption in tissue culture. Science 163, 1450. 1969. —

116. Veda, K. és mts.: Cortical hyperostosis following long term administration of prostagndin E, in infants with cyanotic congenital heart disease. J. Pediatr. 98, 834. 1980. — 117. Vaes, O.: Excretion of acid and of lysosomal acid hydroxylase enzyme during bone resorption induced in tissue culture by parathyroid hormone. Expl. Cell. Res. 39, 470, 1968. — 118. Vaes, G.: Cellular biology and biochemical mechanism of bone resorption: A review of recent developments on the formation, activation and mode of action of osteoclasts. Clin. Orthop. 231, 239. 1988. - 119. Walker, G. D.: Bone resorption restored in osteopetronic mice

transplanted of normal bone marrow and spleen cells. Science 190, 784. 1975. — 120. Walker,

G. D.: The induction of osteopetrotic changes in hypophysectomized, throparathyroidectomized and intact rats of various ages. Endocrinology 89, 1389. 1971. — 121. Warshawsky, H. és mts.: Direct in vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J. Cell. Biol. 85, 682. 1981. — 122. Wong, G. L.: A comparison of the PTH-dependent cAMP response in osteoclastic ans osteoblastic bone cells. Mineral Electrol. Metab. 10, 77. 1984. — 123. Yamasaki, K. és mts.: Prostaglandin as a mediator of bone resorption induced by experimental tooth movement in rats. J. Dent. Res. 59, 1635. 1980. — 124. Yamasaki, K. és mts.: Clinical application of prostaglandin El (PGE1) upon orthodontic tooth movement. Amer. J. Orthod. 85, 508. 1984. — 125. Yang, Y. és mts.: Synthetic human parathyroid hormone fragment stimulates prostaglandin E2 synthesis by chick calvariae. Endocrinology 120, 63. 1987. — 126. Zambonin-Zalone, A. és mts.: Isolated osteoclasts in primary culture: First observations on structure and survival in culture media. Anat. Embryol. 165, 405. 1982. — 127. Zambonin-Zalone, A. és mts.: Resorption of vital or devitalized bone by isolated osteoclasts in vitro. The role of lining cells. Cell. Tissue Res. 235, 561. 1984. — 128. Zséli,és mts.: Decreased calcitonin reserve in accelerated postmenopausal osteoporosis Hormone Metab. Res. 17, 696. 1985. — 129. Zséli, J. és mts.: Calcitonin secretion in steak gonad syndrome (Turner’s syndrome). Calc. Tissue Int. 39, 297. 1986.

l)r. Gera, I.: The hormonal regulation of the hone metabolism

During the past two decades our ideas about the regulation of bone formation and resorption has been expanded. At the cellular level we have learnt more about the hormonal control of the osteoblastic bone formation, the osteoclastic bone resorption and the role of the non

119